[Present possibilities of the treatment of malignant ventricular arrhythmia in coronary disease].
G
G
Breithardt
M
M
Borggrefe
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery / Q000628:therapy*; D002036:Bundle of His / Q000601:surgery; D005117:Cardiac Complexes, Premature / Q000628:therapy; D003327:Coronary Disease / Q000150:complications*; D003452:Cryosurgery; D004554:Electric Countershock / Q000295:instrumentation; D004562:Electrocardiography; D006329:Heart Conduction System / Q000601:surgery; D006352:Heart Ventricles / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D010138:Pacemaker, Artificial; D013610:Tachycardia / Q000601:surgery / Q000628:therapy
D000889:Anti-Arrhythmia Agents
Heutige Möglichkeiten der Therapie maligner ventrikulärer Herzrhythmusstörungen bei koronarer Herzkrankheit.